PAVmed, Inc. (PAVM)
5.28
+0.19
(+3.73%)
USD |
NASDAQ |
Sep 04, 16:00
5.20
-0.08
(-1.52%)
After-Hours: 20:00
PAVmed Research and Development Expense (Quarterly) : 2.048M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.048M |
| March 31, 2026 | 1.388M |
| December 31, 2025 | 1.828M |
| September 30, 2025 | 1.088M |
| June 30, 2025 | 0.79M |
| March 31, 2025 | 0.787M |
| December 31, 2024 | 0.807M |
| September 30, 2024 | 1.542M |
| June 30, 2024 | 1.641M |
| March 31, 2024 | 1.941M |
| December 31, 2023 | 3.595M |
| September 30, 2023 | 3.161M |
| June 30, 2023 | 3.469M |
| March 31, 2023 | 4.439M |
| December 31, 2022 | 6.674M |
| September 30, 2022 | 6.202M |
| June 30, 2022 | 6.74M |
| March 31, 2022 | 5.932M |
| December 31, 2021 | 6.969M |
| September 30, 2021 | 5.305M |
| June 30, 2021 | 4.258M |
| March 31, 2021 | 3.315M |
| December 31, 2020 | 3.642M |
| Date | Value |
|---|---|
| September 30, 2020 | 2.619M |
| June 30, 2020 | 2.133M |
| March 31, 2020 | 2.628M |
| December 31, 2019 | 2.255M |
| September 30, 2019 | 1.519M |
| June 30, 2019 | 1.405M |
| March 31, 2019 | 1.451M |
| December 31, 2018 | 1.371M |
| September 30, 2018 | 1.171M |
| June 30, 2018 | 1.148M |
| March 31, 2018 | 0.5625M |
| December 31, 2017 | 0.5555M |
| September 30, 2017 | 0.7049M |
| June 30, 2017 | 0.7017M |
| March 31, 2017 | 0.6567M |
| December 31, 2016 | 0.607M |
| September 30, 2016 | 0.5785M |
| June 30, 2016 | 0.355M |
| March 31, 2016 | 0.1791M |
| December 31, 2015 | 0.1413M |
| September 30, 2015 | 0.2645M |
| June 30, 2015 | 0.0674M |
| March 31, 2015 | 0.016M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 892.00M |
| AngioDynamics, Inc. | 8.178M |
| Alphatec Holdings, Inc. | 18.17M |
| AtriCure, Inc. | 25.67M |
| Baxter International, Inc. | 125.00M |